Unknown

Dataset Information

0

Phenotypic and population differences in the association between CILP and lumbar disc disease.


ABSTRACT:

Background

Lumbar disc disease (LDD) is one of the leading causes of disability in the working-age population. A functional single-nucleotide polymorphism (SNP), +1184T-->C, in exon 8 of the cartilage intermediate layer protein gene (CILP) was recently identified as a risk factor for LDD in the Japanese population (odds ratio (OR) 1.61, 95% CI 1.31 to 1.98), with implications for impaired transforming growth factorbeta1 signalling.

Aim

To validate this finding in two different ethnic cohorts with LDD.

Methods

This SNP and flanking SNPs were analysed in 243 Finnish patients with symptoms of LDD and 259 controls, and in 348 Chinese subjects with MRI-defined LDD and 343 controls.

Results and conclusion

The results showed no evidence of association in the Finnish (OR = 1.35, 95% CI 0.97 to 1.87; p = 0.14) or the Chinese (OR = 1.05, 95% CI 0.77 to 1.43; p = 0.71) samples, suggesting that cartilage intermediate layer protein gene is not a major risk factor for symptoms of LDD in Caucasians or in the general population that included individuals with or without symptoms.

SUBMITTER: Virtanen IM 

PROVIDER: S-EPMC2598035 | biostudies-literature | 2007 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Phenotypic and population differences in the association between CILP and lumbar disc disease.

Virtanen I M IM   Song Y Q YQ   Cheung K M C KM   Ala-Kokko L L   Karppinen J J   Ho D W H DW   Luk K D K KD   Yip S P SP   Leong J C Y JC   Cheah K S E KS   Sham P P   Chan D D  

Journal of medical genetics 20070112 4


<h4>Background</h4>Lumbar disc disease (LDD) is one of the leading causes of disability in the working-age population. A functional single-nucleotide polymorphism (SNP), +1184T-->C, in exon 8 of the cartilage intermediate layer protein gene (CILP) was recently identified as a risk factor for LDD in the Japanese population (odds ratio (OR) 1.61, 95% CI 1.31 to 1.98), with implications for impaired transforming growth factorbeta1 signalling.<h4>Aim</h4>To validate this finding in two different eth  ...[more]

Similar Datasets

| S-EPMC5067264 | biostudies-literature
| S-EPMC5687669 | biostudies-literature
| S-EPMC6990568 | biostudies-literature
| S-EPMC10523726 | biostudies-literature
| S-EPMC8793002 | biostudies-literature
| S-EPMC6122412 | biostudies-literature
| S-EPMC7946938 | biostudies-literature